A股異動 | 敦煌種業跌停 2019年預虧1.7億元 或被實施退市風險警示
格隆匯1月21日丨敦煌種業(600354.SH)今日跌停,現報4.91元,暫成交3693萬元,最新總市值25.9億元。敦煌種業昨日盤後發公告稱,預計公司2019年度淨利潤虧損1.7億元左右,上年同期虧損2.18億元。因連續兩年虧損,公司股票可能被上交所實施退市風險警示。報告期內,國內玉米種子行業整體市場競爭激烈,農作物新品種不斷湧現,市場競爭壓力仍然很大,公司主營業務仍處於虧損狀態;此外,公司擬計提資產減值損失及信用減值損失準備,影響金額9100萬元左右。此外據悉,敦煌種業曾發重組公告稱,擬通過發行股份方式購買北京首農股份的控制權,首農集團旗下的畜牧板塊將實現曲線上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.